Innovation in gene therapies is hard, but also potentially ground-breaking and biotechnology firm Medera is taking its decades-long journey in the space to the public markets just as hits its next steps in the clinical process.
This week, we speak with Medera CEO Ronald Li, and Kenneth Wong, CEO and Chairman of Keen Vision Acquisition Corp. The two announced a $622 million dollar combination in September.
Ron explains how Medera has leveraged years of innovations including the capacity to grow miniature human hearts for testing as it advances gene therapies for heart failure that do not rely on animal testing and could prove significantly cheaper than alternatives.
Kenneth tells us why he believes those details align well with the changing regulatory and investment climate around drug development. And, why he views Medera as being a more mature investment play in the biotech space than many of the others coming to market today.
Give it a listen.
Silver Pegasus Acquisition Corp. (NASDAQ:SPEGU) has filed for a $150 million SPAC with Roth Capital Partners underwriting the offering. The new SPAC is laser-focused on finding a semiconductor or “systems solutions” target, which is an intriguing space given that the sector has been in the crosshairs of trade restrictions by nearly all countries involved. That...
At the SPAC of Dawn Space de-SPACs have been among the big winners from the market’s initial parsing of the Trump administration 2.0’s policy priorities, with Rocket Lab (NASDAQ:RKLB) gaining +30%, Redwire (NYSE:RDW) +51% and Intuitive Machines (NASDAQ:LUNR) +23.9%. Redwire got the double boost of Trump’s bullish words on space and also the announcement that...
Iron Horse Acquisitions Corp. II has filed for a $250 million SPAC with D. Boral Capital underwriting under its new name. D. Boral emerged in November from a messy dispute at the top of investment bank EF Hutton that was concluded with Joseph Rallo taking the EF Hutton trademark and departing the firm while David...
At the SPAC of Dawn This shortened trading week could be a rocky one as the market takes in the first wave of initiatives out of the new US administration and will have what are technically the first Trump 2.0 jobs numbers released on Thursday. It should be somewhat quieter for SPACs working through their...
Terms Tracker for the Week Ending January 17, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We may be heading into a Polar Vortex, but SPACs managed to generate some heat this week with three more IPOs. For those keeping count,...